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Abstract Poor diet and lifestyle exposures are implicated in substantial global increases in non-
communicable disease burden in low-income, remote, and Indigenous communities. This
observational study investigated the contribution of the fecal microbiome to influence host
physiology in two Indigenous communities in the Torres Strait Islands: Mer, a remote island where
a traditional diet predominates, and Waiben a more accessible island with greater access to
takeaway food and alcohol. Counterintuitively, disease markers were more pronounced in Mer
residents. However, island-specific differences in disease risk were explained, in part, by
microbiome traits. The absence of Alistipes onderdonkii, for example, significantly (p=0.014)
moderated island-specific patterns of systolic blood pressure in multivariate-adjusted models. We
also report mediatory relationships between traits of the fecal metagenome, disease markers, and
risk exposures. Understanding how intestinal microbiome traits influence response to disease risk
exposures is critical for the development of strategies that mitigate the growing burden of
cardiometabolic disease in these communities.
Introduction
Changes in dietary and lifestyle risk exposures are implicated in substantial global increases in the
non-communicable disease burden (World Health Organization, 2014). This relationship has been
particularly evident in remote and resource-limited communities, where increasing access to highly-
processed, high-calorie foods, and alcohol (World Health Organization, 2014; Popkin et al., 2012)
has been linked to a dramatic rise in metabolic syndrome and cardiovascular disease (Yeates et al.,
2015; Hu, 2011). In Australia, for example, rates of chronic inflammatory and metabolic disease that
are now three times higher in Aboriginal and Torres Strait Islanders populations than in their non-
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Indigenous counterparts (Zhao et al., 2008; Hodge et al., 2010), with particularly high prevalence
in very remote communities (Arnold et al., 2016; Azzopardi et al., 2018). This disparity in disease
burden contributes substantially to health inequality (Anderson et al., 2016) and is replicated in
remote Indigenous populations across the world (Sonnenburg and Bäckhed, 2016).
The role of host-microbiome interactions in shaping the impact of changing risk exposures is
increasingly recognized (Clemente et al., 2018; Wen and Duffy, 2017; Levy et al., 2017). Intestinal
microbial populations exert a profound influence over host metabolism, energy homeostasis, and
innate and adaptive immunity (Martin et al., 2019; Morgan et al., 2015; O’Keefe et al., 2015), and
are highly responsive to dietary and lifestyle exposures (David et al., 2014; Engen et al., 2015;
He et al., 2018). Our understanding of these interactions is based on the analysis of predominantly
urban, high income, European and North American populations. However, associations between the
intestinal microbiome and population geography (Brooks et al., 2018), ethnicity (Vangay et al.,
2018), and cultural background (Queensland Health, 2017) are well characterized. Since the influ-
ence of the microbiome on host physiology is likely to be similarly context-dependent, existing mod-
els of microbiome-mediation may not be appropriate for remote Indigenous communities in
resource-limited settings. Instead, the complexity of interactions between diet, environment, life-
style, human genetics, intestinal microbiology, and other factors, necessitate accurate modeling of
changing patterns of disease at a community-level, and such efforts should arguably focus on those
communities at greatest risk.
To investigate the role of the intestinal microbiome in defining the health impacts associated with
changing risk exposures, we focused on two Indigenous communities in the Torres Strait Islands, an
archipelago that lies between Australia’s Cape York Peninsula and Papua New Guinea. Inhabitants
of Mer (Murray Island), the most remote inhabited island in the Torres Strait, continue to consume a
largely traditional diet, including local oily fish and garden produce. By contrast, those living in the
regional center, Waiben (Thursday Island), have direct transport links to mainland Australia and
ready access to takeaway food and alcohol. In keeping with the Indigenous people across Australia,
the Melanesian Meriam people that populate these islands exhibit high rates of cardiovascular dis-
ease, type 2 diabetes, and cancer (Australian Institute of Health and Welfare, 2018). We hypothe-
sized that intestinal microbiome characteristics would reflect assessed risk exposures, including age,
diet, and lifestyle, and that a mediatory and modifying relationship between risk-associated micro-
biome traits and physiological markers of metabolic disease would be evident.
Results
Study population characteristics
According to Australian national averages (Australian Bureau of Statistics, 2019; Shannon, 2002),
9.1% of adult Australians consumed at least one sugar-sweetened beverage each day and 51% con-
sumed at least two servings of fruit. Furthermore, 67% of the Australian adult population are classi-
fied as being overweight or obese, and 4.1% have type 2 diabetes. In contrast to these national
patterns, 53% of the study cohort consumed at least one sugar-sweetened beverage each day.
While 70% consumed at least two servings of fruit each day, 76% of the study population were over-
weight or obese and 39% had type 2 diabetes.
Island-specific differences in exposure to chronic disease risk factors
Study participants were drawn equally from Waiben, the main commercial and administrative center
of the Torres Strait Islands (n = 50), and Mer, a smaller, more remote, island (n = 50). There were no
island differences in participant gender (males: n = 27 in Waiben, n = 24 in Mer, p=0.548) or in the
prevalence of current smokers (smokers: n = 17 in Waiben, n = 16 in Mer, p=0.832). Residents of
Mer largely consumed a diet that is traditional in the Torres Strait Islands (Niccoli and Partridge,
2012), including frequent consumption of fresh seafood. In comparison, Waiben residents had a
more ‘westernized’ diet, characterized by significantly higher consumption of takeaway food and
alcohol, and lower consumption of seafood (Table 1). Although current dogma suggests such dietary
habits would be associated with increased chronic disease risk, increased levels of chronic disease
risk markers were not observed for Waiben residents. Specifically, Mer residents had significantly
(p<0.05) greater systolic blood pressure, mean arterial pressure (MAP), C-reactive protein, IL-12, IL-
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Age [years] 40 (31, 54) 58 (36, 65) 0.003 NA
Exposure chronic disease risk factors
Sugar-sweetened beverage
consumption [serves/day]
1 (0, 1) 1 (0, 1) 0.576 0.562
Fruit consumption [serves/day] 2 (1, 3) 2 (1, 2) 0.680 0.682
Vegetable consumption [serves/day] 3.5 (2.0, 5.0) 3.5 (2.0, 4.0) 0.609 0.606
Takeaway consumption [serves/week] 1 (0, 2) 0 (0, 1) 0.011 0.009
Seafood consumption [serves/week] 2 (1, 3) 2 (1, 5) 0.020 0.021
Alcoholic beverage
consumption [serves/day]
0.33 (0.00, 0.99) 0.20 (0.00, 1.88) 0.597 0.592
Smoking [cigarettes/day] 0.00 (0.00, 5.25) 0.00 (0.00, 2.25) 0.804 0.800
Physical activity [min/week] 180 (90, 236) 210 (150, 360) 0.925 0.925
Biological chronic
disease risk factors
Glucose [mmol/L] ‡ 5.2 (4.7, 5.7) 5.6 (4.8, 6.5) 0.056 0.050
HbA1c [mmol/mol] ‡ 38 (34, 42) 43 (36.5, 45) 0.127 0.109
Systolic blood pressure [mmHg] 121 (112.5, 129.5) 129 (115.3, 139.5) 0.028 0.025
Mean arterial pressure [mmHg] 87.8 (72.0–113.7) 95.8 (61.0–126.3) 0.034 0.033
Body mass index [kg/m2] 31.1 (25.8, 37.9) 32.1 (25.5, 36.5) 0.893 0.893
Waist circumference [cm] 105 (92, 116) 116 (101, 125) 0.019 0.016
Waist to hip ratio 0.62 (0.53, 0.69) 0.68 (0.61, 0.75) 0.035 0.027
Inflammatory biomarkers ‡
Interferon g [pg/mL] 0.69 (0.61, 0.83) 0.96 (0.67, 1.18) <0.001 <0.001
C-Reactive protein [mg/L] 0.36 (0.23, 0.51) 1.36 (0.63, 1.76) <0.001 <0.001
Interleukin-1b [pg/mL] 0.39 (0.19, 0.61) 0.37 (0.23, 0.5) 0.534 0.536
Interleukin-12p40 [pg/mL] 1.98 (1.26, 3.47) 6.32 (3.31, 11.37) <0.001 <0.001
Interleukin-12p70 [pg/mL] 0.46 (0.41, 0.51) 0.82 (0.62, 1.07) <0.001 <0.001
Interleukin-13 [pg/mL] 1.72 (1.48, 1.94) 1.82 (1.82, 2.07) 0.008 0.008
Interleukin-15 [pg/mL] 7.37 (4.36, 10.7) 8.76 (6.89, 12.23) 0.281 0.272
Interleukin-18 [pg/mL] 11.34 (4.57, 18.17) 21.38 (13.26, 37.51) <0.001 <0.001
Interleukin-4 [pg/mL] 4.97 (4.61, 6.09) 6.80 (5.95, 9.23) <0.001 <0.001
MCP-1/CCL2 [pg/mL] 52.77 (32.89, 88.41) 111.60 (67.65, 149.9) <0.001 <0.001
Tumor necrosis
factor a [pg/mL]
0.17 (0.11, 0.30) 0.47 (0.40, 0.68) <0.001 <0.001
Species-alpha diversity
Count [Chao1 species richness] 68.5 (64.0, 72.3) 68.0 (57.8, 73.3) 0.805 0.805
Distribution [Shannon
evenness index]
0.68 (0.61, 0.71) 0.71 (0.66, 0.75) 0.027 0.026
Variety [Shannon diversity index] 2.83 (2.50, 2.98) 2.94 (2.73, 3.20) 0.061 0.060
Results are median (Q1, Q3).
* ANOVA between Mer and Waiben.
† ANCOVA between Mer and Waiben adjusted for age.
‡ analysis performed on log-transformed data. Abbreviations: MCP: Monocyte Chemoattractant Protein; MIP: Macrophage Inflammatory Protein.
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18, and IFNg, compared to Waiben residents. While not achieving statistical significance (p=0.100),
the prevalence of T2D in Mer residents was also greater than in Waiben residents (48% versus 30%,
respectively; Table 1).
The explanation for such a proatherogenic biomarker profile in Mer residents was not immedi-
ately apparent. Mer residents were significantly older than Waiben residents (mean age [years]: 41.5
versus 51.7; p=0.003), a recognized risk factor for chronic disease (Arumugam et al., 2011). How-
ever, significant differences in measures of blood pressure and inflammatory markers remained even
after adjusting for age (Table 1).
Fecal microbiome characteristics
Exploratory factor analysis of species relative abundance revealed six major factors
(Supplementary file 1a). However, differences in microbiota traits were evident between the two
island communities. Mer residents displayed higher species evenness (Table 1), even after adjust-
ment for age (p=0.026). While the fecal microbiota composition for the study population as a whole
was broadly in keeping with that described for adult populations more generally
(Human Microbiome Project Consortium, 2012; Gassasse et al., 2017), the communities differed
in their species-level microbiota composition (P[perm]=0.001, pseudo-F = 2.125, 9882 permuta-
tions); Figure 1a, Figure 1—figure supplement 1. Linear discriminant analysis effect size (LEfSe)
identified differentially enriched species in each subpopulation (Figure 1b), which were phylogeneti-
cally diverse and represented five distinct bacterial phyla (Figure 1c). For example, the Proteobacte-
ria and Euryarchaeota phyla were significantly higher in Mer compared to Waiben in both
unadjusted and age-adjusted models (Supplementary file 1b). Klebsiella pneumoniae (NCBI:
txid573; Proteobacteria) and Escherichia coli (NCBI:txid562; Proteobacteria), common causes of
enteric and disseminated infection, and the important methanogen, Methanobrevibacter smithii
(NCBI:txid2173; Euryachaeota), were also significantly enriched in Mer.
Characteristics of fecal microbiome metabolic capacity were then assessed. The prevalence of 18
microbial pathways, which accounted for 5% of the total community pathways identified by
HUManN2, differed significantly between Mer and Waiben populations (Figure 2a). Three pathways
that were more highly represented in the Mer population related to energy-generating glycolysis
pathways, including homolactic fermentation (ANAEROFRUCAT-PWY: homolactic fermentation,
p=0.005), glycolysis I (from glucose-6-phosphate, p=0.004), glycolysis II (from fructose-6-phosphate,
PWY-5484, p=0.004), and glycolysis VI pathway (PWY66-400, p=0.004). Pathways that were more
highly represented in the Waiben population included those relating to amino acid biosynthesis,
including L-valine (VALSYN-PWY, p=0.006), L-isoleucine biosynthesis I and IV (ILEUSYN-PWY,
p=0.006; PWY-5104, p=0.004), L-lysine biosynthesis VI (PWY-5097, p=0.009), and L-lysine, L-threo-
nine and L-methionine biosynthesis II super pathway (PWY-724, p=0.004). In addition, pathways
relating to aromatic acid biosynthesis (COMPLETE-ARO-PWY, p=0.004) and the precursor, choris-
mate (ARO-PWY, p=0.004 and PWY-6163, p=0.008) were also more prevalent in the Waiben popula-
tion. Stratification of these pathways based on microbial taxa indicated that island-specific
differences in glycolytic pathways were primarily accounted for by differences in the abundance of E.
coli, while those relating to the biosynthesis of aromatic acid compounds were largely explained by
the distribution of members of the Roseburia genus, including Roseburia intestinalis and Roseburia
hominis (Figure 2b). The contribution of these bacterial taxa to the pathways identified was in keep-
ing with the trends observed between the two island populations when metabolic capacity was
assessed at a microbiota-wide level (FDR p<0.05; Figure 2—figure supplement 1).
Microbiome as a mediator of exposure-inflammation relationships
From the data presented above, it is clear that our understanding of the factors that shape the
microbiome composition and inflammatory profile of this population of Australian Torres Strait
Islanders is incomplete. We, therefore, explored whether differences in the characteristics of the
intestinal microbiome substantially influenced the relationship between exposure to dietary, lifestyle,
and environmental factors (age, gender, island, smoking status and intakes of fruits, vegetables,
takeaways, sugar-sweetened beverages, seafood, and alcohol) on circulating concentrations of
inflammatory biomarkers. When comparing the various theoretical frameworks, structural equation
modeling suggested that microbiome factors may potentially mediate the relation between
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Figure 1. Island-specific differences in the species composition of the microbiome. (a) Non-metric Multidimensional Scaling of the Bray Curtis similarity
resemblance matrix, with ellipses at 95% confidence interval. n = 100 (b) Fold differences in LDA mean proportions of differentially abundant species in
Waiben and Mer. Bars were sorted based on the sequential ranking of significance and separated by the two populations. Only taxa significant at a
logarithmic LDA score 3 and a factorial Kruskal-Wallis test Alpha (a)0.05 are shown. n = 100 (c) A phylogenetic tree based on the NCBI taxonomy of
Figure 1 continued on next page
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exposures and pathophysiology, when considering inflammatory profile (Supplementary file 1c, Fig-
ure 3, Figure 3—figure supplement 1). Most notable was the positive association sugar-sweetened
beverage consumption had with the Biomarker Factor 3 (the latent construct representing IL13, IL15,
IFN gamma, and IL1b), as well as with Species Factor 1, which consisted of Haemophilus parainfluen-
zae, Bacteroides ovatus and fragilis, members of the Veillonella genus, Eubacterium halli, Anaeros-
tipes hadrus, Roseburia intestinalis, Ruminococcus obeum, Ruminococcus gnavus, Lachnospiraceae
bacterium 5_1_63FAA and Lachnospiraceae bacterium 8_1_57FAA (Figure 3). Interestingly, a posi-
tive association was also observed between Biomarker Factor 3 and Species Factor 1. These associa-
tions were of particular interest, in part, because, when compared to the Australian national
average, these communities consumed considerably more sugar-sweetened beverages. Of particular
interest was the influence of Lachnospiraceae bacterium 8_1_57FAA (NCBI:txid665951) as in boot-
strapped analyses of both islands combined, this was found to mediate the overall association
between increased sugar-sweetened beverage consumption and increased serum concentration of
IL-15 (Figure 4a, Figure 4—figure supplement 1). In fact, mediation by Lachnospiraceae bacterium
8_1_57FAA was found to significantly (p=0.044) account for (median [95% confidence intervals]) 13.5
(0.4, 44.2) percent of the total effect of sugar-sweetened beverages on IL-15 concentrations in unad-
justed models, and account for 16.5 (0.6, 60.0) percent of the age-adjusted total effect (p=0.040).
The mediation of the relationship between sugar-sweetened beverages and IL-15 remained signifi-
cant, even after including island in the age-adjusted model, with Lachnospiraceae bacterium
8_1_57FAA significantly accounting for 21.2 (1.5, 78.9) percent of the total observed association
Figure 1 continued
differentially abundant species identified using LEfSe. All species designated ‘unclassified’ were not used in generating the tree. Branches/edges are
colored according to phylum rank classification and terminal nodes/species labels are colored based on study site overrepresentation. n = 100.
The online version of this article includes the following figure supplement(s) for figure 1:
Figure supplement 1. Taxonomic profile of the 100 Torres Strait Islander participants included in the study.
Figure 2. Functional pathways of the gut microbiota that significantly differed in abundance between Mer and Waiben communities. (a) Pathway
abundances at the whole community level were statistically compared between the groups, and the 95% confidence interval of the effect-size for each
pathway was determined using a non-parametric bootstrap method. (b) The heatmap represents community pathway abundances stratified into
significant contributions from bacterial species to between-group differences. The color scale depicts the magnitude of the difference of stratified
pathway abundances between the groups. All statistical comparisons were performed using the Mann-Whitney test and corrected for multiple testing
using the false discovery rate method. Statistical significance for all comparisons was determined at p<0.05. Heatmap boxes with an ‘-’ indicated non-
significant stratified pathway abundance differences between the groups.
The online version of this article includes the following figure supplement(s) for figure 2:
Figure supplement 1. Heatmap representation of stratified contribution to whole-community pathway abundances.
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(p=0.032). Despite the total association being ameliorated, the moderation by Lachnospiraceae bac-
terium 8_1_57FAA remained significant even in the multivariate-adjusted model (p=0.036).
We then sought to identify the biological significance of this relationship by looking at the role of
Lachnospiraceae bacterium 8_1_57FAA in mediating the observed relationship between sugar-
sweetened beverage consumption and blood pressure (Supplementary file 1d). Mean arterial
Figure 3. Structural equation model describing the pattern of interrelationships between exposures, microbiome, and host inflammation. A modified
path diagram of the final SEM supporting the mediatory effect of the gut microbiota on inflammation. The heatmaps represent direct associations of
diet, behavior, and demographics with the gut microbiota and inflammatory biomarkers. Only significant paths of the effect of the gut microbiota on
inflammation are shown. Standardized b coefficients are reported. Species Factors 1–6 denote latent variables of the community gut microbiota
modeled as exploratory factor analysis (EFA) regression scores of the species relative abundance; Biomarker Factors 1–3 denote latent variables
representing community inflammatory biomarkers as grouped using EFA. *p 0.1–0.05, **p 0.05–0.001, ***p<0.001. Edge colors : Green: positive
association; red: negative association. Black arrows indicate the direction of association of diet, demographics, and behavioral exposures with both
inflammatory biomarkers and the gut microbiota.
The online version of this article includes the following figure supplement(s) for figure 3:
Figure supplement 1. Theoretical models for assessing the structure of associations between the various human exposures, the gut microbiota, and
the host’s inflammatory profile.
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pressure was greater in Mer than in Waiben in both unadjusted and age-adjusted models. Lachno-
spiraceae bacterium 8_1_57FAA mediated a positive association between sugar-sweetened bever-
age intake and MAP in unadjusted (Figure 4b) and age-adjusted models (Figure 4—figure
supplement 2). Even after controlling for factors that could influence this relationship, Lachnospira-
ceae bacterium 8_1_57FAA continued to mediate a positive association between sugar-sweetened
beverage intake and MAP for the combined island populations. In contrast to the significant media-
tory effect of Lachnospiraceae bacterium 8_1_57FAA, no significant direct relationship between
sugar-sweetened beverage intake and diastolic blood pressure was observed, indicating the consid-
erable role played by the gut bacteria in the association of diet and pathophysiology in this context.
The position of Lachnospiraceae bacterium 8_1_57FAA withing the Lachnospiraceae family is indi-
cated in Figure 4—figure supplement 3.
Figure 4. Lachnospiraceae bacterium 8_1_57FAA mediates the unadjusted relation of sugar-sweetened beverage intake with the serum concentration
of Interleukin 15 and mean arterial pressure. (a) Lachnospiraceae bacterium 8_1_57FAA mediates the unadjusted relation of sugar-sweetened beverage
intake with the serum concentration of Interleukin 15. The total effect (95% confidence interval) for the model was 0.054 (0.023, 0.090), P-value: <0.001.
n = 100 (b) Lachnospiraceae bacterium 8_1_57FAA mediates the unadjusted relation of sugar-sweetened beverage intake with mean arterial pressure.
The total effect (95% confidence interval) for the model was  0.006 (–1.530, 1.420), P-value: 0.950. n = 100 a ACME (average causal mediation effects); b
ADE (average direct effects).
The online version of this article includes the following figure supplement(s) for figure 4:
Figure supplement 1. Role of Lachnospiraceae bacterium 8 1 57FAA in mediating the relation of sugar-sweetened beverage intake with the serum
concentration of Interleukin 15.
Figure supplement 2. Role of Lachnospiraceae bacterium 8 1 57FAA in mediating the relation of sugar-sweetened beverage intake with the mean
arterial pressure.
Figure supplement 3. 16S rRNA-based phylogeny of Lachnospiraceae.
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Microbiome as a moderator of exposure-pathophysiology relationships
Mediation is not the only way in which the microbiome can influence how dietary, lifestyle, and envi-
ronmental factors influence pathophysiology. The microbiome can also interact with these relation-
ships in such a way that the association of dietary, lifestyle, and environmental factors with
pathophysiology depends on the presence/absence of a particular microorganism. Given that sys-
tolic blood pressure is an important chronic disease risk factor, and was higher in Mer than in Wai-
ben systolic blood pressure was selected for an analysis of interaction. A microbiome-wide
interaction study was performed, and, after correcting for multiple comparisons, Alistipes onderdon-
kii (NCBI:txid328813) was identified as a microorganism that significantly interacted with the island-
systolic blood pressure relationship (Figure 5). The pattern of interaction was such that a failure to
detect Alistipes onderdonkii in the gut microbiome was associated with increased systolic blood
pressure, but only in Mer, and when these microorganisms were present, systolic blood pressure in
Mer was identical to that of Waiben residents. These effect modifications remained even after
adjusting for various diet and lifestyle exposure variables, suggesting that higher systolic blood pres-
sure in Mer residents, despite Mer residents having lower traditional exposure risk factors, may be
explained by an interaction between geographic location and the gut microbiome.
Discussion
We report the intestinal microbiome to modulate cardiometabolic risk in two Torres Strait Islander
populations. In particular, Lachnospiraceae 8_1_57FAA was found to mediate associations between
sugar-sweetened beverage consumption and systemic inflammation and MAP in both communities
assessed, while Alistipes onderdonkii was found to moderate systolic blood pressure, but only in res-
idents of one of the two study islands.
Changes in diet and lifestyle are implicated in fundamental and ongoing shifts in population
health (World Health Organization, 2014; Samuel et al., 2008). In particular, rates of cardiometa-
bolic diseases are reaching epidemic proportions in many communities (Yeates et al., 2015;
Schutte et al., 2005). Evidence has pointed to the gut microbiome as a critical determinant of
response to risk exposures through its influence on host immune- and metabolic-regulation
(Thaiss et al., 2016; Kaibe et al., 2005). Understanding the contribution of the gut microbiome to
population health outcomes is particularly important in remote communities where chronic disease
Figure 5. Systolic blood pressure in the context of an interaction between Alistipes onderdonkii and island systolic blood pressure. (a) Unadjusted
model, (b) age-adjusted model, and (c) multivariate-adjusted model which includes the adjustment for age, body mass index, gender, smoking status,
and intakes of fruits, vegetables, takeaways, sugar-sweetened beverages, seafood, and alcohol. Only significant P values (p<0.05) are shown n = 100.
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burden is disproportionately high. However, models that have been developed using data from
exclusively western populations may not be accurate in such contexts, given required assumptions
about common risk exposures, disease susceptibilities, and intestinal microbiology. In our investiga-
tion of intestinal microbiology in two remote Indigenous communities, we identify fecal microbiome
traits to be significant determinants of the association diet, lifestyle, and environmental factors have
with disease risk.
The relationships between risk exposures, microbiome traits, and biological risk, that we report
are highly biologically credible. For example, serum IL-15 concentration has been shown to be
higher in patients with cardiovascular disease, compared to patients without the disease
(Krolopp et al., 2016). IL-15 is a potent regulator of glucose uptake (Kameyama and Itoh, 2014),
although whether its production is increased as a result of high sugar consumption is not currently
well-understood. Lachnospiraceae bacterium 8_1_57FAA (NCBI:txid665951) was found to mediate
the overall association between increased sugar-sweetened beverage consumption and increased
serum concentration of IL-15, even after adjusting for multiple factors that may influence this media-
tory relationship. We also observed a relationship between sugar-sweetened beverage consumption
and diastolic blood pressure. Members of Lachnospiraceae, a family of bacteria in the order of Clos-
tridiales and part of the normal human gut microbiota, have been implicated in the risk of metabolic
(Liu et al., 2018; Lippert et al., 2017; Schirmer et al., 2016) and cardiovascular (Lippert et al.,
2017) disease. In particular, associated Lachnospiraceae bacterium 8_1_57FAA has been associated
with host cytokine levels (Wang et al., 2019) and BMI (Turnbaugh et al., 2007), although the under-
lying mechanisms that underpin these relationships remain poorly understood. Lachnospiraceae bac-
terium 8_1_57FAA is an uncultured taxon, identified through metagenomic analysis of human fecal
material (Jie et al., 2017). It represents a little-known bacterium on the phylogenetic periphery of
the Lachnospiraceae family. As applies to many of the taxa identified through metagenomics as influ-
encing risk exposures-metabolic disease relationships, detailed characterization of this bacterium is
required to better understand mediatory mechanisms.
Furthermore, when considering systolic blood pressure, we identified a significant interaction
between A. onderdonkii and geographic location. When this taxon was present, no difference in sys-
tolic blood pressure between the residents of the two islands was observed. However, when A.
onderdonkii was not detected in the gut microbiota of Mer residents, systolic blood pressure was
significantly higher compared to residents of Waiben, suggesting that the absence of this bacteria
was important for systolic blood pressure, but only within one island community. Members of the
Alistipes genus are depleted in individuals with atherosclerotic cardiovascular disease
(Rowley et al., 2003) and such an interaction could contribute substantially to the observed patterns
of disease burden between the two islands that did not fit established models of risk.
While these findings contribute to our understanding of the fundamental relationships between
commensal microbiology and non-communicable disease risk at a global level, it is important to be
mindful of the fact that this study was undertaken because the cardiometabolic disease was identi-
fied as a matter of substantial and growing concern by the participating communities. It is therefore
essential to consider how the insight gained from this analysis can be used to improve the health of
the individuals living in these two communities. The existence of microbiome-modulation of non-
communicable disease risk highlights the importance of access to food of high nutritional value,
while identification of specific microbiome markers of increased disease susceptibility suggests a
basis for more accurate prediction of an individual’s relative disease risk. However, perhaps most
exciting is our identification of moderation relationships, in which the absence of specific taxa, such
as A. onderdonkii, increased disease risk within the exposure context of these communities.
The importance of understanding determinants of disease risk at a community level was further
highlighted by the inflammatory profiles of the participants, as compared to those reported previ-
ously for remote Indigenous communities on the Australian mainland. For example, extremely high
levels of CRP have been reported in remote Aboriginal communities (Wang and Hoy, 2010;
Miller et al., 2002), with reported links to both dietary quality and risk of T2D (Wang and Hoy,
2010). By contrast, CRP concentrations amongst our study population were not markedly elevated,
suggesting underlying differences in morbidity, potentially including lower rates of chronic infection.
Our understanding of how differences in microbiome traits influence host physiology, and ulti-
mately, health outcomes, remains in its relative infancy. In part, this is due to the sheer complexity of
microbiome-host interactions and the number of different potential points of direct or indirect
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interaction between the gut microbes and the host. Analysis of the functional capacity of the micro-
biome (based on bacterial pathways encoded by the metagenome), enabled us to identify differen-
ces in functional capacity between study populations. However, functional redundancy within the gut
microbiome, as well as widespread cross-metabolism, makes predicting the impact of such differen-
ces in overall microbiome output extremely difficult. We suggest that analysis of the gut metabo-
lome could provide important insight into the nature of host-microbiome interactions. Furthermore,
in addition to assessment of inflammatory cytokines, other factors that potentially contribute to diet-
microbe-host interactions, such as plasma metabolites, warrant investigation.
A limitation of our study was its reliance on a relatively small sample, leading to an increased like-
lihood of type two statistical errors. However, we were still able to observe statistically significant
associations that had biological relevance. Furthermore, it is important to note that the 100 partici-
pants in this study represented a substantial proportion of these two small island communities. Our
study also employed a cross-sectional design, which meant that it was not possible to rule out the
possibility of reverse causation and or establish causality. Given the contribution of genetic, develop-
mental factors, and other unmeasured confounders to risk factor response, refinement of our models
based on longitudinal analysis with a more complete set of exposure and outcome data would pro-
vide a valuable extension to this work.
Our findings highlight the potential contribution of the intestinal microbiome to community-spe-
cific patterns of cardiometabolic health through the mediation of relationships of specific diet, life-
style, and environmental factors with host pathophysiology. These relationships have relevance for
our understanding of changing burdens of non-communicable disease, particularly in remote, low-
income, and Indigenous populations.
Materials and methods
Participants and setting
This observational study recruited participants from the Well Persons Health Check (WPHC). In 1997,
the Australian government started a broad community health promotion and screening programme
called the WPHC (Berger et al., 2020) conducted by the Torres and Cape Hospital and Health Ser-
vice (TCHHS). Through WPHC several Indigenous (Aboriginal and/or Torres Strait Islander) communi-
ties in northern Queensland were screened annually for sexually transmitted infections and chronic
cardiovascular as well as chronic metabolic conditions. In 2016, TCHHS collaborated with James
Cook University (Zenadth Kes Health Partnership; Weiland, 1978) to conduct these surveys in two
Australian island communities, Waiben and Mer. These islands are located in the Torres Strait Islands
(TSI) archipelago, which lies in the waters separating the far northern continental Australia’s Cape
York Peninsula (northern-most tip of Queensland) and the Western Province of Papua New Guinea,
off the continent of Australia. Mer (Murray Island) is a 4.3 km2 remote island located on the eastern
periphery of the Torres Strait region, 210 km northeast of Waiben and 340 km west of Port Moresby,
with a population of 450 in 2016. The island is less connected with no known fast-food outlet. Wai-
ben (Thursday Island) is a 3.5 km2 landmass located about 39 km north of Cape York Peninsula with
a population of 2938 in 2016. It is the administrative and commercial center of the Torres Strait
Island Region.
In addition to the health check that was a standard component of the WPHC, participants con-
sented to have additional health data collected for research purposes. Verbal consent was used
whenever a written one could not be obtained. In addition to individual consent, parent/legal guard-
ian consent was obtained for all participants younger than 18 years. The study incorporated all
WPHC participants who identified as Aboriginal and/or Torres Strait Islander and attended the
screening in October, November, and December 2016. There were 214 individuals aged 15 years
and older who participated in the October, November, and December 2016 WPHC and identified as
Aboriginal and/or Torres Strait Islander. Participants were excluded due to insufficient survey infor-
mation (n = 2) and or not providing consent to participate in the research component of the health
check (n = 1). Only participants who provided stool samples for metagenomic sequencing (total
n = 100; 50 participants from each site) were then included in the current analysis. The study was
granted ethical approval by the Far North Queensland Human Research Ethics Committee (HREC/
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16/QCH/70–1059). In addition, written support from the local Community Council, Primary Health
Care Service, and TCHHS was also provided (Weiland, 1978).
Participant demographic, dietary, and behavioral factors
We collected the island of residence, age, gender, physical activity, and daily alcohol consumption
as well as smoking status. Dietary intake of seafood, takeaway foods, vegetables, fruits, and sugar-
sweetened beverages was determined using a culturally-appropriate food frequency questionnaire
that assessed food and beverage consumption through the use of non-leading questions
(Weiland, 1978).
Age, gender, height, weight, ethnicity, systolic blood pressure (SBP), diastolic blood pressure
(DBP), known diabetes status, and known diabetes therapy were documented from WPHC clinical




Body mass index (BMI; kg/m2) was computed from weight and height records. Hypertension was
defined as SBP >140 and/or DBP > 90. Tobacco smoking and alcohol consumption were assessed
using a standarized questionnaire.
Clinical sample collection
A summary of key resources utilized, including sample collection kits, DNA isolation and library prep
kits, DNA sequencing platform, and software is provided in Supplementary file 1e Each participant
provided a sample of stool, blood, and urine. The stool was collected by participants using the
OMNIgene GUT collection kit (DNA Genotek, Ontario, Canada), according to manufacturer’s
instructions. Briefly, the stool was deposited in a sterile container, transferred into the OMNIgene
tube using the provided spatula, mixed with the stabilizing liquid, and stored at room temperature
until collection. Blood and urine were collected by TCHHS as described previously (Zhao et al.,
2008).
Measurements of inflammatory and cardiometabolic markers
Concentrations of various biomarkers in blood and/or urine were measured using chemistry multi-
plex immunoassays and enzyme-linked immunosorbent assays (ELISA; Bolger et al., 2014) as fol-
lows: Interleukins (IL) IL-1b, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p40, IL-12p70, IL-13, IL-15, IL-17A, IL-18,
and IL-33; type II interferon (IFNg ), monocyte chemoattractant protein 1 (MCP1/CCL2), macrophage
inflammatory protein (MIP-1a/CCL3), and tumor necrosis factor alpha (TNFa) were measured using
Luminex High Sensitivity (8-plex and 9-plex) Human ProcartaPlex Panels. Serum C-reactive protein
(CRP) was measured using the CRP Human ProcartaPlex Simplex Kit. Serum lipopolysaccharide-bind-
ing protein (LBP) was also measured using Human LBP ELISA Kit. Random blood glucose (RBG) and
glycated hemoglobin or hemoglobin A1c (HbA1c) were measured using blood glucose meter and
Haemoglobin A1c (HbA1c) (Human) ELISA Kit, respectively. All commercial assays were performed
according to manufacturers’ instructions.
DNA isolation and metagenomic sequencing
Microbial DNA was isolated from stool samples using DNeasy Powerlyzer PowerSoil Kit (Qiagen, Hil-
den, Germany). DNA yield was determined in Qubit Fluorometric Quantification using Quant-iT
High-Sensitivity dsDNA Assay Kit. Libraries for shotgun metagenomic sequencing were fragmented
using Nextera XT Library Preparation Kit v2 (Illumina Inc, San Diego, CA) and indexed using the Illu-
mina Nextera XT Index Kit v2 according to manufacturer’s instructions. Amplicon libraries were then
sequenced on the Illumina HiSeq 2500 platform at the SAHMRI David R Gunn Genomics Suite using
Illumina HiSeq SBS 2  125bp v4 kit (Illumina Inc). Reads were converted into FASTQ format using
bcl2fastq v.1.8.4. On average, 16,666,136 sequencing reads were obtained from each sample before
quality filtering.
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Bioinformatic processing
Paired-end reads were adapter- and quality-filtered using Trimmomatic v.0.36 (Truong et al., 2015)
with the following parameters: PE ILLUMINACLIP:TruSeq3-PE:3:30:10 LEADING:10 MINLEN:30 SLI-
DINGWINDOW: 4:30; HEADCROP:10. Samples included in the downstream analysis had at least 7.4
million paired-end reads of at least 91 bp in length after quality control. The quality of reads was
checked before and after this process using FastQC v.0.11.5.
Using the quality-controlled paired-end reads, taxonomic profiling was performed using
the metagenomic phylogenetic analysis (MetaPhlAn) v.2.6 (Franzosa et al., 2018), which uses a
database of clade-specific markers to quantify microbiota constituents at the species and higher tax-
onomic levels. The generation of the abundance of metabolic pathways was performed using
HUMAnN2 (Asnicar et al., 2015). Taxonomic and metabolic profiles for both islands were visualized
using GraPhlAn v.0.9.7 (Whittaker, 1972). Sequenced metagenomic data were submitted to the
National Center for Biotechnology Information (NCBI) Sequence Read Archive (SRA) under BioPro-
ject ID PRJNA503909. Summary of the quality-controlled fecal microbiome sequencing reads is
shown in Supplementary file 1f.
Statistical analysis
Statistical analyses and graphical illustrations were accomplished in R software for statistical comput-
ing, Primer 7, GraphPad Prism 7, and Statistical Analysis Software (SAS/STAT) suite. Rare taxa, pres-
ent in less than 40% of the participants at <1% relative abundance, were excluded from the analysis.
Alpha-diversity is defined as a local measure of average species diversity in a community. (Whit-
taker, 1972; Jost, 2007). To estimate the species alpha diversity in Mer and Waiben, we examined
the microbial composition in each community using the vegan (Oksanen et al., 2018) package in R.
(R Development Core Team, 2010) Accordingly, the ’estimate’ function was used to calculate
Chao1’s measure of richness; a measure of the number of species (or other taxonomic levels) present
at a site. The ’diversity’ function was used to estimate the Shannon-Wiener Index (H’); a measure of
how many different types of species are present in the community. Species diversity takes into
account both species richness and the dominance or evenness of the species. Evenness measures
homogeneity in a community in terms of species relative abundances. A community in which all spe-
cies are proportionately common is regarded as stable and has a high degree of evenness. Since
vegan does not provide a function for Shannon’s evenness/equitability (E), we used a modified R
function to estimated E by dividing the actual diversity (H’) with the maximum possible diversity
value (Hmax). The reasoning is, H’ decreases when the species composition is more uneven and
reaches a maximum with the highest evenness. Therefore, when all species are equally common,
Hmax ¼ ln S (where S is the total number of species), and E ¼ H
0  Hmax. Differences in species com-
position within Mer and Waiben were analyzed in GraphPad using the Mann-Whitney U-test the with
FDR multiple-testing adjustment.
Beta diversity is defined as the change in species composition from one community to the next
(Whittaker, 1972; Jost, 2007). Species relative abundances were square root-transformed and used
to calculate Bray-Curtis distances of samples dissimilarity in Primer6. To test the null hypothesis of
no difference in species relative abundance between islands, we used permutational multivariate
analysis of variance (PERMANOVA) model on the Bray-Curtis dissimilarity data under a partial (type
III) sum of squares, a fixed-effects sum to zero for mixed terms, 10,000 unrestricted parameters per-
mutation of residuals and Monte Carlo tests in Primer v.6. The matrix of Bray-Curtis distances was
also used as input to calculate non-metric multidimensional scaling (NMDS) coordinates using vegan
package in R (R Development Core Team, 2010). The first and second components were used to
create an ordination plot using ggvegan.
Linear discriminant analysis (LDA) effect size (LEfSe) v.1.0 (Segata et al., 2011) was used to deter-
mine the species typifying the disparities between Mer and Waiben populations. To achieve this, a
table of pre-filtered species relative abundances was normalised to ensure values for each species
across all samples summed up to 1 million. Island of sample origin was used as a class variable. Non-
parametric factorial Kruskal-Wallis (KW) sum-rank tests were then performed to detect species with
significant (a <0.05) differential abundance with respect to the class. The species that were signifi-
cantly different between islands were used to build an LDA model from which the relative difference
among classes was used to rank the features. The threshold for the logarithmic LDA score was set
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at 3. Finally, the ranked effect-size values were visualized in a LEfSe plot. Significant functional
pathways were stratified into bacterial species, and the resulting stratified pathways were filtered to
include only those that were present in at least 80% in either the Mer or Waiben populations. Strati-
fied pathway abundances that remain significantly different between Mer and Waiben were deter-
mined using the Mann-Whitney U-test with the FDR multiple-testing adjustment, at a significance
threshold of 0.05.
Correlations between measurements of each circulating biomarker in the host and the taxonomic
or functional profiles of the microbiota were analyzed using Spearman’s rank correlation imple-
mented in the Hmisc package in R and visualized using ggplot2 and gplots packages in R. Signifi-
cance thresholds for the coefficients of association and P-values were respectively set at rho ()  |
0.3| and p-value0.05, Benjamini-Hochberg (BH) adjusted for multiple hypothesis testing.
Structural Equation modeling (SEM) was performed in R using the lavaan package (Rosseel, 2012)
to assess the direct and indirect associations of host diet, behavior and demographics with host bio-
markers of inflammation. Initial path diagrams were visualized using semPlot (Epskamp and
Epskamp, 2017) package in R and partly modified into heatmaps using ggplot2. Briefly, we mod-
eled the inflammatory biomarkers using exploratory factor analysis to identify three latent (unob-
served) constructs, with TNF-a, IL-4, IL-12P70, as indicators for the first latent variable (Biomarker
Factor 1), CRP, IL-18, and MCP1 as indicators for the second latent variable (Biomarker Factor 2),
and IL-15, IL-33, IFNg, and IL-1b indicators for the third latent variable (Biomarker Factor 3).
Observed variables potentially important to inflammation, including alcohol consumption, smoking,
diet (fruits, vegetables, fish, and intake of fatty and sugary foods typical of takeaways and soft-
drinks), and demographics (age, gender, BMI, and island/study site) were also included. Four possi-
ble association frameworks were developed to explain the link between the specific exposures (age,
gender, island, smoking status and intakes of fruits, vegetables, takeaways, sugar-sweetened bever-
ages, seafood, and alcohol), the microbiome, and host physiology (Figure 3—figure supplement 1):
Framework (1) the gut microbiome mediates the exposure-inflammation relationship; Framework (2)
the gut microbiome influences pathophysiology but is not influenced by risk exposures; Framework
(3) the gut microbiome is influenced by exposures but does not influence pathophysiology; and
Framework (4) exposure risk factors are associated with the inflammatory profile, and
the inflammatory profile predicts the gut microbiome composition. The model was assessed using
the confirmatory factor analysis (CFA) function and estimated using the robust variant of maximum
likelihood parameter estimation (MLR) with robust (Huber-White) standard errors and default boot-
strapping (asymptomatically equivalent to Yuan-Bentler correction statistic) to account for data non-
normality, presence of dichotomous and categorical variables, and correction for multiple hypothesis
testing. Equivalents of the final SEM model were investigated and defined by adjusting
the directionality of correlation or inferring co-variation instead of causation. Standard SEM fit guide-
lines (Hooper and Coughlan, 2008; Hu and Bentler, 1999), that is, chi-squared P-value; (c2 P-value)
>0.05; comparative fit index (CFI) >0.8; standardized root-mean residuals (SRMR) <0.08; root-mean-
square error of approximation (RSMEA) <0.05; and the lowest Akaike information criterion (AIC)
were used to assess model-data fit for each of the four theoretical frameworks.
Individual mediation relationships between host exposures, host gut microbiology (as the media-
tor), and host pathophysiology (as the outcome) were evaluated using the ‘mediation’ package in R.
Fitted objects of the exposure and the mediator were analyzed using the ‘mediate’ function with
nonparametric bootstrapping methods. Interaction was assessed through the incorporation of an
interaction term into regression models.
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